Skip to content

Clinical trials

Phase 4 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 4 Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20062
20074
20082
20094
20102
20112
20122
20132
20141
20151
20163
20173
20202
20215
20223
20234
20243
20251
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Unknown status12
Recruiting9
Active, not recruiting4
Withdrawn4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong4
University of Sao Paulo General Hospital4
Chinese SLE Treatment And Research Group3
GlaxoSmithKline3
Peking Union Medical College Hospital3
Tuen Mun Hospital3
Human Genome Sciences Inc., a GSK Company2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2
Johns Hopkins University2
Mallinckrodt2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic57
Lupus Nephritis7
Arthritis, Rheumatoid5
Atherosclerosis5
Autoimmune Diseases5
Arthritis, Juvenile4
Dermatomyositis3
Scleroderma, Systemic3
Antiphospholipid Syndrome2
Arthritis, Psoriatic2

Trials

Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.